These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21443963)

  • 1. A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness.
    Gunther VJ; Putnak R; Eckels KH; Mammen MP; Scherer JM; Lyons A; Sztein MB; Sun W
    Vaccine; 2011 May; 29(22):3895-904. PubMed ID: 21443963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of dengue virus strains for human challenge studies.
    Mammen MP; Lyons A; Innis BL; Sun W; McKinney D; Chung RC; Eckels KH; Putnak R; Kanesa-thasan N; Scherer JM; Statler J; Asher LV; Thomas SJ; Vaughn DW
    Vaccine; 2014 Mar; 32(13):1488-94. PubMed ID: 24468542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults.
    Thomas SJ; Eckels KH; Carletti I; De La Barrera R; Dessy F; Fernandez S; Putnak R; Toussaint JF; Sun W; Bauer K; Gibbons RV; Innis BL
    Am J Trop Med Hyg; 2013 Jan; 88(1):73-88. PubMed ID: 23208878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of production of live attenuated dengue vaccines: a case study of the Instituto Butantan, Sao Paulo, Brazil.
    Mahoney RT; Francis DP; Frazatti-Gallina NM; Precioso AR; Raw I; Watler P; Whitehead P; Whitehead SS
    Vaccine; 2012 Jul; 30(32):4892-6. PubMed ID: 22406455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants.
    Watanaveeradej V; Simasathien S; Nisalak A; Endy TP; Jarman RG; Innis BL; Thomas SJ; Gibbons RV; Hengprasert S; Samakoses R; Kerdpanich A; Vaughn DW; Putnak JR; Eckels KH; Barrera Rde L; Mammen MP
    Am J Trop Med Hyg; 2011 Aug; 85(2):341-51. PubMed ID: 21813857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKT cells promote Th1 immune bias to dengue virus that governs long-term protective antibody dynamics.
    Choi Y; Saron WA; O'Neill A; Senanayake M; Wilder-Smith A; Rathore AP; St John AL
    J Clin Invest; 2024 Aug; 134(18):. PubMed ID: 39088280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated NS1 serum levels reduce CD119 expression and CXCL-10 synthesis in patients with dengue hemorrhagic fever.
    Garcia FG; Helmo FR; Silva MVD; Rodrigues V; Oliveira CJF; Teixeira LAS; Rogério AP; Teixeira DNS
    Rev Soc Bras Med Trop; 2024; 57():e00410. PubMed ID: 39082520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological Cross-Reactivity in Zoonotic Flaviviral Infections of Medical Importance.
    Gomes da Silva P; Seixas Dos Reis JA; Nogueira Rodrigues M; da Silva Ardaya Q; Mesquita JR
    Antibodies (Basel); 2023 Feb; 12(1):. PubMed ID: 36975365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled Human Infection Models To Accelerate Vaccine Development.
    Choy RKM; Bourgeois AL; Ockenhouse CF; Walker RI; Sheets RL; Flores J
    Clin Microbiol Rev; 2022 Sep; 35(3):e0000821. PubMed ID: 35862754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Soluble Mediator Profiles and Networks During Acute Infection With Distinct DENV Serotypes.
    Coutinho-da-Silva MS; Sucupira PHF; Bicalho KA; Campi-Azevedo AC; Brito-de-Sousa JP; Peruhype-Magalhães V; Rios M; Teixeira-Carvalho A; Coelho-Dos-Reis JGA; Antonelli LRDV; de Rezende VB; de Melo FLR; Garcia CC; Silva-Andrade JC; da Costa-Rocha IA; Bastos MS; da Rocha LA; Silva VA; Ferreira EDS; Marinho EPM; Costa AG; Gomes MS; Amaral LR; Furtado ECDS; da Silva EVP; Ramos BA; Dos Santos ÉB; Freitas MNO; Vasconcelos PFDC; Martins-Filho OA; Araújo MSS; Ferreira MS; Martins LC
    Front Immunol; 2022; 13():892990. PubMed ID: 35711447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Dengue 4 as Dominant Serotype During 2017 Outbreak in South India and Associated Cytokine Expression Profile.
    Gowri Sankar S; Mowna Sundari T; Alwin Prem Anand A
    Front Cell Infect Microbiol; 2021; 11():681937. PubMed ID: 34447698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model.
    Hanley JP; Tu HA; Dragon JA; Dickson DM; Rio-Guerra RD; Tighe SW; Eckstrom KM; Selig N; Scarpino SV; Whitehead SS; Durbin AP; Pierce KK; Kirkpatrick BD; Rizzo DM; Frietze S; Diehl SA
    Nat Commun; 2021 May; 12(1):3054. PubMed ID: 34031380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Host Innate Immunity by Non-Coding RNAs During Dengue Virus Infection.
    Rajput R; Sharma J; Nair MT; Khanna M; Arora P; Sood V
    Front Cell Infect Microbiol; 2020; 10():588168. PubMed ID: 33330133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue: A Minireview.
    Harapan H; Michie A; Sasmono RT; Imrie A
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Human Primate Models of Dengue Virus Infection: A Comparison of Viremia Levels and Antibody Responses during Primary and Secondary Infection among Old World and New World Monkeys.
    Muhammad Azami NA; Takasaki T; Kurane I; Moi ML
    Pathogens; 2020 Mar; 9(4):. PubMed ID: 32230836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1.
    Friberg H; Martinez LJ; Lin L; Blaylock JM; De La Barrera RA; Rothman AL; Putnak JR; Eckels KH; Thomas SJ; Jarman RG; Currier JR
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31969476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus.
    Gil L; Martín A; Lazo L
    Front Immunol; 2019; 10():2946. PubMed ID: 31921194
    [No Abstract]   [Full Text] [Related]  

  • 18. Time elapsed between Zika and dengue virus infections affects antibody and T cell responses.
    Pérez-Guzmán EX; Pantoja P; Serrano-Collazo C; Hassert MA; Ortiz-Rosa A; Rodríguez IV; Giavedoni L; Hodara V; Parodi L; Cruz L; Arana T; White LJ; Martínez MI; Weiskopf D; Brien JD; de Silva A; Pinto AK; Sariol CA
    Nat Commun; 2019 Sep; 10(1):4316. PubMed ID: 31541110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Strategies and Current Trends in Designing Antiviral Drugs against Dengue Fever via Targeting Host-Based Approaches.
    Ahammad F; Tengku Abd Rashid TR; Mohamed M; Tanbin S; Ahmad Fuad FA
    Microorganisms; 2019 Aug; 7(9):. PubMed ID: 31466307
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Chesnut M; Muñoz LS; Harris G; Freeman D; Gama L; Pardo CA; Pamies D
    Front Cell Infect Microbiol; 2019; 9():223. PubMed ID: 31338335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.